Mounjaro (Tirzepatide) — 8-Week Program
Mounjaro (tirzepatide) is a clinically proven, prescription-only weight management medication and a cornerstone of Patient First’s longevity medicine practice.
It works by simultaneously activating GLP-1 and GIP receptors — two key metabolic hormones that regulate appetite, caloric intake, and blood sugar control — making it one of the most effective science-backed tools available for medically supervised weight management.
This 8-week program combines the 2.5mg starting dose (Weeks 1–4) with the 5mg progression dose (Weeks 5–8) into a single, continuous course — designed for patients beginning their longevity medicine journey who want the full initial dose sequence prescribed and dispensed together.
This program is for individuals who have been assessed, cleared, and prescribed by our doctors following a mandatory pre-screening consultation and diagnostic workup. It is a medically supervised program designed not just for weight loss, but for long-term metabolic health.
Pre-screening is required before purchase. Please contact us to arrange your consultation and diagnostic tests before proceeding.

















